«BMP7 is active in stimulating brown fat development in cells in culture and in test animals, so we are very
excited in having this opportunity to determine its potential as a
new therapeutic approach for obesity and type 2 diabetes,» said Dr Ronald Kahn.
While pluripotent stem cell - based therapies are an
exciting option, this
approach has several barriers to its application, although Iqbal Ahmad (University of Nebraska Medical Center, USA) has now proposed the use of a «non ‐ cell autonomous» reprogramming strategy as a
new and improved
therapeutic approach [2].